2018
DOI: 10.1016/j.ejmp.2018.05.013
|View full text |Cite
|
Sign up to set email alerts
|

Quantifying the robustness of [ 18 F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
38
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(41 citation statements)
references
References 31 publications
1
38
1
Order By: Relevance
“…The NEMA NU 2-2012 IQ phantom was used in this study consisting of a background volume of 9400 ml and six fillable spheres with inner diameters of 10,13,17,22,28, and 37 mm. The phantom was filled with different 18 F-FDG concentrations.…”
Section: A1 Nema Image Quality Phantommentioning
confidence: 99%
See 2 more Smart Citations
“…The NEMA NU 2-2012 IQ phantom was used in this study consisting of a background volume of 9400 ml and six fillable spheres with inner diameters of 10,13,17,22,28, and 37 mm. The phantom was filled with different 18 F-FDG concentrations.…”
Section: A1 Nema Image Quality Phantommentioning
confidence: 99%
“…Another challenge facing radiomic features is the establishment of their measurement error (i.e., reproducibility, repeatability, and reliability). Several studies have shown that the majority of the 18 F‐FDG PET radiomic features are sensitive to numerous sources such as image acquisition, reconstruction protocols, or delineation method . Our study investigates the relationship of multiple confounding factors, including different activity uptake levels, thereby simulating tracers showing differences in uptake.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Most prior studies have focused solely on the effects of inter-observer variability in manual tumor delineation to identify radiomics features with high robustness [17,18]. In fact, quanti cation of tumor delineation and tolerance assessment of the differences are likely more important in developing standardized research.…”
Section: Introductionmentioning
confidence: 99%
“…Unlike in lung cancer patients, 18 F-FDG PET has already been established to play a role in the application of target volume contouring [21]. In addition, the artifacts caused by tumor location, anatomical boundaries, clinical situations, and patient cooperation during examination have a great impact on the quality of the contouring [22,23]. 18 F-FDG, a marker of glycolysis in cells, has a short half-life, high imaging spatial resolution, and excellent nuclear and chemical features [24], which make it the most widely used radioactive tracer for PET.…”
Section: Discussionmentioning
confidence: 99%